Elanco Animal Health Inc SEC filings ELAN
Elanco Animal Health Inc has 1,015 filings in SEC EDGAR's recent list, going back to Sep 19, 2018. Its latest annual report, Form 10-K, was filed on Feb 24, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 5, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 5, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| SD | Specialized disclosure (conflict minerals) | May 27, 2026 | — |
| SD | Specialized disclosure (conflict minerals) | May 30, 2025 | — |
| SD | Specialized disclosure (conflict minerals) | May 28, 2024 | — |
| UPLOAD | Letter from the SEC | Mar 12, 2024 | — |
| DFAN14A | Filing | Feb 29, 2024 | — |
| SD | Specialized disclosure (conflict minerals) | May 25, 2023 | — |
| 25-NSE | Delisting notice | Feb 1, 2023 | — |
| SD | Specialized disclosure (conflict minerals) | May 26, 2022 | — |
| DFAN14A | Filing | Aug 10, 2021 | — |
| DFAN14A | Filing | Aug 9, 2021 | — |
| DFAN14A | Filing | Aug 2, 2021 | — |
| DFAN14A | Filing | Jul 1, 2021 | — |
| DFAN14A | Filing | Jun 17, 2021 | — |
| DFAN14A | Filing | Jun 16, 2021 | — |
| DFAN14A | Filing | Jun 16, 2021 | — |
| SD | Specialized disclosure (conflict minerals) | May 25, 2021 | — |
| CERT | Nyse certification | Jan 27, 2020 | — |
| 8-A12B | Form 8-a12b | Jan 27, 2020 | — |
| 425 | 8-k | Jul 2, 2019 | — |
| EFFECT | Filing | Jun 14, 2019 | — |
| CORRESP | Letter to the SEC | Jun 12, 2019 | — |
| UPLOAD | Letter from the SEC | Jun 4, 2019 | — |
| EFFECT | Filing | May 29, 2019 | — |
| CORRESP | Letter to the SEC | May 24, 2019 | — |
| UPLOAD | Letter from the SEC | May 23, 2019 | — |
| 425 | Filing | May 9, 2019 | — |
| 425 | Filing | Apr 26, 2019 | — |
| 425 | Filing | Apr 26, 2019 | — |
| 425 | 8-k | Apr 26, 2019 | — |
| UPLOAD | Letter from the SEC | Mar 22, 2019 | — |
| 425 | Filing | Mar 11, 2019 | — |
| EFFECT | Filing | Mar 4, 2019 | — |
| CORRESP | Letter to the SEC | Feb 28, 2019 | — |
| CORRESP | Letter to the SEC | Feb 22, 2019 | — |
| 425 | Filing | Feb 20, 2019 | — |
| 425 | Filing | Feb 8, 2019 | — |
| 425 | Filing | Feb 8, 2019 | — |
| 425 | Filing | Feb 8, 2019 | — |
| 425 | 8-k | Feb 8, 2019 | — |
| 425 | Filing | Feb 7, 2019 | — |
| EFFECT | Filing | Sep 19, 2018 | — |
Showing 41 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ELAN (NYSE)
- Fiscal year ends
- December 31
- Headquarters
- Indianapolis, IN
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1739104
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.